$108.32
-1.35[-1.23%]
At close: Apr 24
$108.32
0[0.00%]
After Hours: 4:00PM EDT
Jazz Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Jazz Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | PM | JAZZ | Q1 | $3.95 | $4.23 | — | — | $892.81M | $960.67M | — | — | Get Alert |
02/28/2024 | PM | JAZZ | Q4 | -$0.07 | $5.16 | $5.02 | -2.71% | $972.12M | $1.01B | $1.01B | 0.20% | Get Alert |
11/08/2023 | PM | JAZZ | Q3 | $5.17 | $4.91 | $4.84 | -1.43% | $940.65M | $965.73M | $972.14M | 0.66% | Get Alert |
08/09/2023 | PM | JAZZ | Q2 | $4.30 | $4.43 | $4.51 | 1.81% | $932.88M | $942.86M | $957.32M | 1.53% | Get Alert |
05/10/2023 | PM | JAZZ | Q1 | $3.73 | $4.24 | $3.95 | -6.84% | $813.72M | $895.37M | $892.81M | -0.29% | Get Alert |
03/01/2023 | PM | JAZZ | Q4 | $4.21 | $0.32 | -$0.07 | -121.88% | $896.73M | $975.59M | $972.12M | -0.36% | Get Alert |
11/09/2022 | PM | JAZZ | Q3 | $4.20 | $4.66 | $5.17 | 10.94% | $838.12M | $939.06M | $940.65M | 0.17% | Get Alert |
08/03/2022 | PM | JAZZ | Q2 | $3.90 | $4.20 | $4.30 | 2.38% | $751.81M | $904.21M | $932.88M | 3.17% | Get Alert |
05/04/2022 | PM | JAZZ | Q1 | $3.92 | $3.83 | $3.73 | -2.61% | $607.58M | $853.52M | $813.72M | -4.66% | Get Alert |
03/01/2022 | PM | JAZZ | Q4 | $4.00 | $3.63 | $4.21 | 15.98% | $665.52M | $865.88M | $896.73M | 3.56% | Get Alert |
11/09/2021 | PM | JAZZ | Q3 | $4.31 | $3.31 | $4.20 | 26.89% | $600.89M | $832.52M | $838.12M | 0.67% | Get Alert |
08/03/2021 | PM | JAZZ | Q2 | $3.71 | $3.42 | $3.90 | 14.04% | $562.44M | $735.62M | $751.81M | 2.20% | Get Alert |
05/04/2021 | PM | JAZZ | Q1 | $0.45 | $3.74 | $3.92 | 4.81% | $534.73M | $611.49M | $607.58M | -0.64% | Get Alert |
02/23/2021 | PM | JAZZ | Q4 | $4.42 | $4.20 | $4.00 | -4.76% | $581.74M | $639.55M | $665.52M | 4.06% | Get Alert |
11/02/2020 | PM | JAZZ | Q3 | $4.10 | $4.08 | $4.31 | 5.64% | $537.70M | $577.58M | $600.89M | 4.04% | Get Alert |
08/04/2020 | PM | JAZZ | Q2 | $4.05 | $3.11 | $3.71 | 19.29% | $534.13M | $504.65M | $562.44M | 11.45% | Get Alert |
05/05/2020 | PM | JAZZ | Q1 | $1.47 | $0.67 | $0.45 | -32.84% | $508.19M | $543.59M | $534.73M | -1.63% | Get Alert |
02/25/2020 | PM | JAZZ | Q4 | $3.64 | $4.12 | $4.42 | 7.28% | $476.46M | $561.69M | $581.74M | 3.57% | Get Alert |
11/05/2019 | PM | JAZZ | Q3 | $3.58 | $3.59 | $4.10 | 14.21% | $469.37M | $525.16M | $537.70M | 2.39% | Get Alert |
Jazz Pharmaceuticals (JAZZ) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $5.02, which missed the estimate of $5.16.
The Actual Revenue was $1B, which beat the estimate of $1B.
Browse earnings estimates, EPS, and revenue on all stocks.